- Home
- Publications
- Publication Search
- Publication Details
Title
Cardiotoxicity Associated with Targeting Kinase Pathways in Cancer
Authors
Keywords
-
Journal
TOXICOLOGICAL SCIENCES
Volume 120, Issue 1, Pages 14-32
Publisher
Oxford University Press (OUP)
Online
2010-12-23
DOI
10.1093/toxsci/kfq378
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cardiac Safety of Lapatinib: Pooled Analysis of 3689 Patients Enrolled in Clinical Trials
- (2012) Edith A. Perez et al. MAYO CLINIC PROCEEDINGS
- The involvement of CaM-KII in insulin induced cell proliferation
- (2011) Richard A. Franklin et al. CELL CYCLE
- Electrophysiological Effects of the Anti-Cancer Drug Lapatinib on Cardiac Repolarization
- (2010) Hyang-Ae Lee et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Emerging Anticancer Therapeutic Targets and the Cardiovascular System
- (2010) Xuyang Peng et al. CIRCULATION RESEARCH
- Molecular Mechanisms of Cardiovascular Toxicity of Targeted Cancer Therapeutics
- (2010) Hui Cheng et al. CIRCULATION RESEARCH
- The Vulnerability of the Heart As a Pluricellular Paracrine Organ
- (2010) Gilles W. De Keulenaer et al. CIRCULATION RESEARCH
- Cancer Therapy-Associated Cardiotoxicity and Signaling in the Myocardium
- (2010) Christian Zuppinger et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Cardiomyocyte PDGFR-β signaling is an essential component of the mouse cardiac response to load-induced stress
- (2010) Vishnu Chintalgattu et al. JOURNAL OF CLINICAL INVESTIGATION
- Gender differences in drug toxicity
- (2010) Tamara J. Nicolson et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- VEGF kinase inhibitors: how do they cause hypertension?
- (2009) Pankaj Bhargava AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk
- (2009) P. J. Barrett-Lee et al. ANNALS OF ONCOLOGY
- Potential Inhibition of PDK1/Akt Signaling by Phenothiazines Suppresses Cancer Cell Proliferation and Survival
- (2009) Jang Hyun Choi et al. Annals of the New York Academy of Sciences
- RETRACTED: Targeting calcium/calmodulin-dependence kinase I and II as a potential anti-proliferation remedy for endometrial carcinomas
- (2009) Noriyuki Takai et al. CANCER LETTERS
- Ligand-Dependent Platelet-Derived Growth Factor Receptor (PDGFR)- Activation Sensitizes Rare Lung Cancer and Sarcoma Cells to PDGFR Kinase Inhibitors
- (2009) U. McDermott et al. CANCER RESEARCH
- Electrocardiographic Characterization of the QTc Interval in Patients with Advanced Solid Tumors: Pharmacokinetic- Pharmacodynamic Evaluation of Sunitinib
- (2009) C. L. Bello et al. CLINICAL CANCER RESEARCH
- Multitarget drugs: the present and the future of cancer therapy
- (2009) Annalisa Petrelli et al. EXPERT OPINION ON PHARMACOTHERAPY
- Molecular Mechanism for SHP2 in Promoting HER2-induced Signaling and Transformation
- (2009) Xiangdong Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial
- (2009) Bernard Escudier et al. JOURNAL OF CLINICAL ONCOLOGY
- Validation of an HPLC-UV method for sorafenib determination in human plasma and application to cancer patients in routine clinical practice
- (2009) B. Blanchet et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- PDK1 coordinates survival pathways and -adrenergic response in the heart
- (2009) K. Ito et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload
- (2009) J. Backs et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate
- (2008) M. L. Telli et al. ANNALS OF ONCOLOGY
- Strategies to reduce the risk of drug-induced QT interval prolongation: a pharmaceutical company perspective
- (2008) C E Pollard et al. BRITISH JOURNAL OF PHARMACOLOGY
- Loss of PTEN attenuates the development of pathological hypertrophy and heart failure in response to biomechanical stress
- (2008) G. Y. Oudit et al. CARDIOVASCULAR RESEARCH
- Both EGFR kinase and Src-related tyrosine kinases regulate human ether-à-go-go-related gene potassium channels
- (2008) De-Yong Zhang et al. CELLULAR SIGNALLING
- Deletion of Ptpn11 (Shp2) in Cardiomyocytes Causes Dilated Cardiomyopathy via Effects on the Extracellular Signal–Regulated Kinase/Mitogen-Activated Protein Kinase and RhoA Signaling Pathways
- (2008) Maria I. Kontaridis et al. CIRCULATION
- Sprycel for Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Resistant to or Intolerant of Imatinib Mesylate
- (2008) M. Brave et al. CLINICAL CANCER RESEARCH
- PDGF-B signaling is important for murine cardiac development: Its role in developing atrioventricular valves, coronaries, and cardiac innervation
- (2008) Nynke M.S. Van den Akker et al. DEVELOPMENTAL DYNAMICS
- Akt as a therapeutic target in cancer
- (2008) Linda S Steelman et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- AMP Activated Protein Kinase-α2 Deficiency Exacerbates Pressure-Overload–Induced Left Ventricular Hypertrophy and Dysfunction in Mice
- (2008) Ping Zhang et al. HYPERTENSION
- Constitutively Active SHP2 Cooperates with HoxA10 Overexpression to Induce Acute Myeloid Leukemia
- (2008) Hao Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Blockade of the erbB2 Receptor Induces Cardiomyocyte Death through Mitochondrial and Reactive Oxygen Species-dependent Pathways
- (2008) Leo I. Gordon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cardiac Toxicity of Sunitinib and Sorafenib in Patients With Metastatic Renal Cell Carcinoma
- (2008) Manuela Schmidinger et al. JOURNAL OF CLINICAL ONCOLOGY
- New Insight Into Epirubicin Cardiac Toxicity: Competing Risks Analysis of 1097 Breast Cancer Patients
- (2008) Marianne Ryberg et al. JNCI-Journal of the National Cancer Institute
- Deletion of Shp2 Tyrosine Phosphatase in Muscle Leads to Dilated Cardiomyopathy, Insulin Resistance, and Premature Death
- (2008) F. Princen et al. MOLECULAR AND CELLULAR BIOLOGY
- Mechanisms of Myocyte Cytotoxicity Induced by the Multiple Receptor Tyrosine Kinase Inhibitor Sunitinib
- (2008) B. B. Hasinoff et al. MOLECULAR PHARMACOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Requirement of protein kinase D1 for pathological cardiac remodeling
- (2008) J. Fielitz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pim-1 kinase antagonizes aspects of myocardial hypertrophy and compensation to pathological pressure overload
- (2008) J. A. Muraski et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effect of the Multitargeted Tyrosine Kinase Inhibitors Imatinib, Dasatinib, Sunitinib, and Sorafenib on Mitochondrial Function in Isolated Rat Heart Mitochondria and H9c2 Cells
- (2008) Yvonne Will et al. TOXICOLOGICAL SCIENCES
- AMPK: a metabolic gauge regulating whole-body energy homeostasis
- (2008) Ricardo Lage et al. TRENDS IN MOLECULAR MEDICINE
- Mitochondrial off targets of drug therapy
- (2008) Kendall B. Wallace TRENDS IN PHARMACOLOGICAL SCIENCES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now